Renal replacement therapy, as with any medical therapy is not without risks. The decision of which therapy and medical device to use should be made by the physician, based on previous experience and on the individual facts and circumstances of the patient.
There is no literature demonstrating that one therapy is clinically better than the other.
The use of anticoagulation is at the discretion of the prescribing physician.
Fresenius Medical Care has successfully completed its merger with NxStage Medical Inc. By strengthening our vertically integrated dialysis business, the merger supports our initiative of driving growth in the core business with innovation, better clinical outcomes through Care Coordination and improving the patient experience. For information about NxStage products and services please continue to use this website. To learn more about Fresenius Medical Care and the merger, visit the links provided.